new med for type 2 diabetes, Avandia (rosiglitazone)
June 1999
You'll see a new med for type 2 diabetes, Avandia (rosiglitazone).
It's a new "glitazone"...similar to Rezulin (troglitazone). A third one, Actos (pioglitazone) will be out later this summer.
These new drugs come at a good time...with all the concern about hepatotoxicity from Rezulin.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber's Letter includes:
- 12 issues every year, with brief articles about new meds and guidelines
- 48+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote